Top Markets
#1 Black Phoenix Black Phoenix +361.13%
#2 Islamic Coin Islamic Coin +158.08%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +56.60%
#5 Akedo Akedo +45.03%
#6 BasedHype BasedHype +32.41%
#7 Acurast Acurast +26.37%
#8 Cryptopia Cryptopia +21.42%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.69%
#10 Playnance Playnance +18.61%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Classifica tra le azioni #41147
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Prezzo delle azioni
$0.04082105
Ultima sincronizzazione: 2024-08-12
Capitalizzazione di mercato
$39.09K
Variazione (1 giorno)
-19.83%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Destiny Pharma plc (DEST)

Categoria

Healthcare
Ricavi di Destiny Pharma plc (DEST)
Ricavi nel Dec 2023 TTM: $1.06M
Secondo gli ultimi rapporti finanziari di Destiny Pharma plc, i ricavi attuali dell'azienda (TTM) sono pari a $1.06M. Nel 2022, l'azienda ha registrato ricavi di $186.91K un aumento rispetto a i ricavi dell'anno 2021, che erano pari a $182.56K. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Destiny Pharma plc da 2013 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $1.06M 0.00%
2023 $1.06M 466.34%
2022 $186.91K 2.39%
2021 $182.56K 972.50%
2020 $17.02K -95.80%
2019 $405.66K 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 1,192,485.48%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 568,715.68%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 955,040.28%
BE